Clinical Trial of Retinal Implants

Retina Implant, the developer of a subretinal implant for the visually impaired, has chosen Wills Eye Institute of Philadelphia, PA to be the lead site of the first clinical trial of the device in North America, the company announced in a news release.

Retina Implant’s proprietary technology will be evaluated in patients with retinitis pigmentosa, the release said.

http://www.osnsupersite.com/view.aspx?rid=81934

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: